Back to Search
Start Over
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
- Source :
- Darby, S, McGale, P, Correa, C, Taylor, T, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, C, Peto, R & Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2011, ' Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials ', Lancet, vol. 378, no. 9804, pp. 1707-16 . https://doi.org/10.1016/S0140-6736(11)61629-2, Lancet, 378(9804), 1707-1716. Elsevier Science, Darby, S, McGale, P, Correa, C, Taylor, C, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, Y, Peto, R 2011, ' Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death : meta-analysis of individual patient data for 10,801 women in 17 randomised trials ', The Lancet, vol. 378, no. 9804, pp. 1707-16 . https://doi.org/10.1016/S0140-6736(11)61629-2, Lancet, 378(9804), 1707-1716. Elsevier Limited
- Publication Year :
- 2011
-
Abstract
- BACKGROUND: After breast-conserving surgery, radiotherapy reduces recurrence and breast cancer death, but it may do so more for some groups of women than for others. We describe the absolute magnitude of these reductions according to various prognostic and other patient characteristics, and relate the absolute reduction in 15-year risk of breast cancer death to the absolute reduction in 10-year recurrence risk. METHODS: We undertook a meta-analysis of individual patient data for 10,801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (pN+) disease. FINDINGS: Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35.0% to 19.3% (absolute reduction 15.7%, 95% CI 13.7-17.7, 2p/=20%), intermediate (10-19%), or lower (<br />link_to_OA_fulltext
- Subjects :
- Oncology
medicine.medical_specialty
Neoplasm Recurrence, Local - epidemiology
medicine.medical_treatment
Population
Breast Neoplasms
Mastectomy, Segmental
Breast cancer
breast cancer
Internal medicine
medicine
Breast-conserving surgery
Humans
education
skin and connective tissue diseases
radiotherapy
Randomized Controlled Trials as Topic
education.field_of_study
business.industry
Estrogen Antagonists - therapeutic use
Mortality rate
Age Factors
Estrogen Antagonists
General Medicine
Breast Neoplasms - mortality - therapy
medicine.disease
Surgery
Unilateral Breast Neoplasms
Radiation therapy
Clinical trial
meta-analysis
Tamoxifen
Receptors, Estrogen
Lymphatic Metastasis
Female
Radiotherapy, Adjuvant
Neoplasm Grading
Neoplasm Recurrence, Local
business
Mastectomy
Subjects
Details
- Language :
- English
- ISSN :
- 01406736
- Database :
- OpenAIRE
- Journal :
- Darby, S, McGale, P, Correa, C, Taylor, T, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, C, Peto, R & Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2011, ' Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials ', Lancet, vol. 378, no. 9804, pp. 1707-16 . https://doi.org/10.1016/S0140-6736(11)61629-2, Lancet, 378(9804), 1707-1716. Elsevier Science, Darby, S, McGale, P, Correa, C, Taylor, C, Arriagada, R, Clarke, M, Cutter, D, Davies, C, Ewertz, M, Godwin, J, Gray, R, Pierce, L, Whelan, T, Wang, Y, Peto, R 2011, ' Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death : meta-analysis of individual patient data for 10,801 women in 17 randomised trials ', The Lancet, vol. 378, no. 9804, pp. 1707-16 . https://doi.org/10.1016/S0140-6736(11)61629-2, Lancet, 378(9804), 1707-1716. Elsevier Limited
- Accession number :
- edsair.doi.dedup.....5dbe2245fa3c4425362890dc43837bec
- Full Text :
- https://doi.org/10.1016/S0140-6736(11)61629-2